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Abstract: Background: Advancement in the surgical techniques should translate into better outcome. The goal of 
this study was to evaluate mortality trends from aortic valve surgery in the United State using large inpatient data-
base. Method: The Nationwide Inpatient Sample (NIS) database was used to calculate the age-adjusted mortality 
rate from aortic valve surgery from 1988 to 2011 in the United State using ICD-9 coding for aortic valve surgery. 
Results: We found that age adjusted mortality rate from aortic valve surgery gradually decreased from 1988 until 
end of study in 2011 to the lowest level with elimination of gender gap that was seen in the early years. For men, age 
adjusted mortality rate from aortic valve surgery in 1988 was 438 per 100,000 with steady reduction to the lowest 
level of 214 per 100,000 in 2011 which remained unchanged from 2007. For women, age adjusted mortality from 
aortic valve surgery was 620 per 100,000 in 1988 with steady reduction to the lowest level of 235 per 100,000 in 
2011 which also remained unchanged since 2007. Conclusion: Age adjusted mortality from aortic valve surgery has 
been gradually decreasing in the last decade and remained stable at the lowest rates in recent years suggesting 
improvement in surgical technics and post-surgical care. 
Keywords: Aortic valve disease, aortic valve replacement surgery, surgical techniques, epidemiology, incidence, 
prevalence, cardiac surgery
Introduction
Aortic valve disease can be caused by a num-
ber of conditions such as aortic stenosis, aortic 
regurgitation or a combination of the two [1]. 
Aortic stenosis has become the most frequent 
type of valvular heart disease in the United 
State [2]. It usually presents as calcified aortic 
stenosis in adults of advanced age represent-
ing roughly 2-7% of the population over the age 
of 65 [2, 3]. Additionally, 2% of the population 
has bicuspid aortic valves with higher risk for 
stenosis [4]. Echocardiography is the key diag-
nostic tool for confirming the presence of aortic 
valvular disease. 
The first human heart valve surgery was a digi-
tal valvotomy of a stenotic aortic valve per-
formed by Tuffier in 1914. The first aortic valve 
replacement surgery was performed by Harken 
and Braunwald. This sparked the concurrent 
development of mechanical prostheses and tis-
sue valves. Aortic valve replacement has been 
the definitive therapy for severe aortic stenosis 
until the introduction of percutaneous aortic 
valve implantation. It remains the standard of 
practice for aortic regurgitation [2].
The standard operative technique includes a 
median sternotomy and extracorporal circula-
tion [5]. Cardiac arrest is then induced by in- 
fusion of blood cardioplegia directly into the 
coronary ostia [5]. The operative mortality is 
approximately 1-3% for aortic valve replace-
ment without coronary bypass surgery (CABG) 
[2]. However, in-hospital (short-term) mortality 
rate has been demonstrated to be 4-8% [6]. 
Some of the clinical predictors of poor out-
comes among the asymptomatic patients in- 
clude older age and presence of atherosclerotic 
risk factors [3]. Once symptoms occur, the pro- 
gnosis becomes dismal [2]. There are several 
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risk factors that can increase operative mor- 
tality [2]. These risk factors include elderly, 
women, symptom severity, ejection fraction, 
and urgency [2]. Advancement in surgical tech-
niques and perioperative care should translate 
into better outcome. The aim of this study was 
to assess the age adjusted mortality rate for 
aortic valve surgery using a large nationwide 
inpatient sample database from 1988-2011 
in the United States. 
Methods
Data source
The National Inpatient sample (NIS) is a prod-
uct of Agency for Healthcare Research and 
Quality’s Healthcare Cost and Utilization Pro- 
ject. This data base is publicly available and 
has been used by policymakers and research-
ers. NIS data base represents nearly 20% sam-
ple of all short-term, general, and specialty hos-
pitals including non-federal serving adults in 
the United States and making the data anony-
mous. NIS also detains information on primary 
and secondary diagnoses and procedures, dis-
charge vital status, and demographics. Asso- 
ciation of discharge data in NIS data set can be 
made available by a unique hospital identifier. 
Sample selection
The Nationwide Inpatient Sample (NIS) data-
base was used to calculate the age-adjusted 
mortality rate from aortic valve surgery. ICD-9-
CM codes for Aortic valve surgery from 1988 
to 2011 in the United State were available. 
Records with ICD-9-CM as primary procedure 
code signifying aortic valve surgery (V43.3) was 
utilized for our statistic. Furthermore, we strati-
fied our data based on gender. 
Statistical analysis
The average age adjusted mortality rates from 
aortic valve surer were calculated by multiply-
year from 1988 to 2011. We used ANOVA tr- 
end analysis for our study. The Statistical Pa- 
ckage for Social Sciences (SPSS) software 
was used for this study and data analysis. A p 
value of less than 0.05 was accepted as statis-
tically significant. 
Results
AV surgery were done in 258,506 patients from 
which 159,346 were male and 99,160 were 
female. We found that age adjusted mortality 
rate from aortic valve surgery gradually de- 
creased from 1988 until 2007 to the lowest 
level and remained stable until end of study in 
2011 with elimination of gender gap that was 
seen in the early years. For men, age adjusted 
mortality rate from aortic valve surgery in 1988 
was 438 per 100,000 with steady reduction to 
the lowest level of 214 per 100,000 in 2011 
which remained unchanged from 2007. For 
women, age adjusted mortality from aortic 
valve surgery was 620 per 100,000 in 1988 
with steady reduction to the lowest level of 235 
per 100,000 in 2011 with stable rate since 
2007 Table 1 and Figure 1.
Discussion
As life expectancy increases and the US popu-
lation ages, there will be a greater number of 
patients with aortic stenosis and increasing 
need for aortic valve replacement or proce-
dures. Based on our results, age-adjusted mor-
tality rates from aortic valve surgery have been 
gradually decreasing in the last decade and 
remaining stable since 2007 suggesting that 
improvements in surgical techniques and post-
surgical care have led to a better outcome. A 
systematic review of predictors of mortality 
after aortic valve replacement found strong evi-
dence to support that mortality is increased by 
emergency surgery [7] while the risk of late 
mortality is increased with older age and pre- 
operative atrial fibrillation [7]. Some other risk 
factors that reduce survival are elderly, abnor-
Table 1. Summary of data
AV surgery total of 258,506 patients Male: 159,346 
Female: 99,160
Age adjusted mortality rate of AVR in male In 1988: 438/100,000
In 2011: 214/100,000
Age adjusted mortality rate of AVR in female In 1988: 620/100,000
In 2011: 235 per 100,000 
ing age specific mortality rates 
with age specific weights for 
available data. We used each 
age-specific rate weighted by 
the proportion of people in th- 
at age group in the U.S. 2000 
standard population. The wei- 
ghted rates were summed ac- 
ross age groups to calculate 
the age adjusted rate for each 
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mal ventricular function, aortic regurgitation, 
infection, end stage renal disease and bypass 
time [7]. Consistent with our results, a study 
performed in North America looked at isolated 
aortic valve replacements and found that mor-
tality decreased more than 30% between 1997 
and 2006 in the presence of diabetes, non-
urgent cases and renal failure among all adults 
[4]. 
Decreased mortality rates despite increasing 
age and co-morbidities may be due to success-
ful risk stratification. A prospective study look- 
ed at 652 patients from January 1999 and 
June 2007 using the EuroSCORE and the STS-
PROM to compare predicted mortality rates of 
patients who were undergoing isolated AVR 
surgery [8]. The EuroSCORE, European system 
for cardiac operative risk evaluation has been 
thought to overestimate mortality rates [8]. 
The STS-PROM (Society of Thoracic Surgeons 
predicted risk of mortality) score is one the 
most accurate score to predict complications 
of AVR [9-11]. The EuroSCORE clearly overesti-
mates the risk of mortality, especially in very 
high-risk patients [8-10]. Investigators argued 
that the EuroSCORE is still based on a 1995 
mortality rate across all cardiac surgeries and 
has not been updated or recalibrated [8]. This 
study concluded that the results of convention-
al AVR are excellent even in high-risk patients 
and the most current scores systematically 
overestimate the risk. The current scores are 
inadequate in identifying patients who are truly 
not suitable for conventional AVR because of a 
high risk [8]. Out of the current available scor-
with co-morbidities signify improvements in 
surgical techniques [11, 12].
A retrospective study looked at patients over 
80 years old undergoing AVR using the data 
from the Department of Veteran Affairs Con- 
tinuous Improvement in Cardiac Surgery Pro- 
gram between 1991 and 2007 [12]. The pati- 
ents were matched by risk profile. Their results 
demonstrated similar mortality rates (5.2% vs 
3.3%; P=.19) for both groups, but higher mor-
bidity rates (21.1% vs 15.5%; P < 0.03) for the 
old patient group aged greater than 80 years 
compared to the younger patients [12]. Similar 
findings were described in a study performed in 
Austria [13]. These findings again illustrate that 
advancements in surgical techniques, improved 
myocardial protection strategies, and better 
perioperative care have led to safer aortic valve 
replacements for the adult populations [12, 
13]. Improvement in surgical techniques 
include the use of retrograde coronary sinus 
perfusion with warm oxygenated blood which 
provides myocardial protection and can 
improve right ventricular protection during ret-
rograde cardioplegia [14]. Surgical advance-
ments have led to an alternative to the cardio-
plegic arrest technique which is the on-pump 
beating heart aortic valve replacement with 
retrograde coronary sinus warm blood perfu-
sion. It has the advantage of maintaining physi-
ologic conditions of the heart throughout the 
procedure and thereby reducing the risk of 
myocardial ischemia [14, 15]. Long cardiopul-
monary bypass time has been shown to be an 
independent risk factor in short term mortality 
rates for elderly patients undergoing primary 
Figure 1. Age adjusted mortality rate from aortic valve replacement based on 
gender using ANOVA trend analysis seen since 1988 with steady reduction 
in mortality. 
ing systems for predicting ra- 
tes of mortality, the STS sco- 
re appears to be the most 
accurate one [8, 9]. In spite of 
the sharply increasing num-
ber of AVRs being performed 
each year, the risk profile of 
patients has worsened over 
time [12]. Despite the fact th- 
at patients are now older with 
increasing prevalence of co-
morbid conditions, the risk of 
perioperative death has de- 
creased significantly [11, 12]. 
These studies are also sug-
gesting that reduction in peri-
operative deaths amongst an 
increasing elderly population 
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isolated aortic valve replacement [16]. Impro- 
vements in CPB time and technique may ex- 
plain the reduction in early mortality rates for 
patients. Additionally, meticulous perioperative 
care with early mobilization is another explana-
tion for the decline in mortality rates [17]. 
The rate of surgical AVR for elderly Medicare 
patients between 1999 and 2011 increased by 
19% and found that women and black patients 
have less procedure but higher mortality rates 
[18]. Additionally, there was a decreased use 
of mechanical prosthetic implants. It has been 
shown that the type of valve used during valve 
surgery does not significantly affect mortality 
rates [11]. The independent factors that pre-
dicted the length of stay included procedural 
urgency, age, renal impairment, cerebrovascu-
lar disease, diabetes, respiratory disease and 
NYHA class [7, 11]. The frequency of periope- 
rative death following tissue AVR was not sig-
nificant (3.1% compared with 2.5% following 
mechanical AVR) [11]. These results conclude 
that the type of AVR should not influence the 
rate of perioperative death nor the postopera-
tive length of stay. However, valve prosthesis-
patient mismatch has been shown to be a 
strong and independent risk factor for short-
term mortality rates among patients undergo-
ing aortic valve surgery [19]. Greater experi-
ence with prosthesis-patient matching may be 
a contributing factor in the declining mortality 
rates after aortic valve surgery. 
An analysis of 41,227 patients undergoing aor-
tic valve surgery from 2004 to 2009, found an 
increased annual volume of aortic valve re- 
placements [20]. The increased volume was 
concluded to be a result of an increasing life 
expectancy with an increasing elderly popula-
tion with aortic stenosis [20]. This study found 
the mortality rate for octogenarians to be 8.1%, 
and an even greater 11.1% for high-risk pati- 
ents. This mortality rate compares with an ov- 
erall mortality rate of 4.5% and a rate of 9.8% 
for high-risk younger patients. This study also 
found a 26% increase in the number of pati- 
ents undergoing aortic valve surgery with a 
70% increase in the octogenarians [20].
Although it has been demonstrated that aortic 
valve surgery has been denied based on older 
age and LV dysfunction [21] surgery should not 
be withheld based on age. Not only have mor-
tality rates progressively declined for aortic 
valve replacements in the last decade, but 
patients appear to be at a greater mortality risk 
and risk of poorer quality of life if refusing to 
have surgery [22]. A study in the UK demon-
strated a > 12-fold increase in mortality risk for 
elderly patients with aortic stenosis refusing 
the operation when they were otherwise fit for 
surgery [21]. AVR or percutaneous aortic valve 
implantation should be strongly considered in 
all patients with severe aortic stenosis irre-
spective of age [22]. Performing an AVR before 
severe LV hypertrophy and dysfunction occurs 
has been shown to optimize survival [22]. For 
younger patients, implanting the largest pos- 
sible prosthesis will help to minimize residual 
gradient. For elderly patients, avoidance of 
complex operations to insert larger prostheses 
can improve survival [22].
Gender has been found to be an independent 
risk for mortality after mechanical aortic valve 
surgery [23]. Additional CABG and redo surgery 
in females predicts survival whereas severely 
impaired LVEF independently predicts survival 
in males [23]. Although age affects survival in 
both sexes independently, gender significantly 
influenced freedom from cardiac death with 
females showing inferior results. We found a 
significant decrease in aortic valve surgery re- 
lated to in-hospital mortality as well as a di- 
sappearing gender gap, with the lowest level 
reached in 2007-2011 across the United 
States. There are several reasons as to why 
there was a previously greater gender gap in 
the age-adjusted mortality rates from 1994-
2002. Reports of the efficacy of appetite sup-
pressant drugs appeared in 1992 [24]. By 
1997 a high incidence of cardiac valve regurgi-
tation was reported in patients who had taken 
the fenfluramine-phentermine combination for 
an average of 11 months [24]. This may have 
contributed to a steady gender gap in mortality 
rates. Additionally, a population-based study 
revealed that women are less often diagnosed 
than men, which could indicate an important 
imbalance in regard to the associated lower 
survival of women [25]. Improvements in diag-
nosis and access to aortic valve surgery sooner 
for females can explain the progressively nar-
rowed gender gap in mortality rates. More re- 
cently, high volume surgical centers appear to 
play a factor in mortality rates for high-risk pa- 
tients undergoing AVR surgery. This study con-
cluded that all hospitals beyond the hinge-point 
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for volume, > 390 cases over the 4-year study 
period, had O/E mortality ratios less than 1 
[25]. However, it was noted that this volume-
outcome relationship identified seemed only 
applicable to high-risk patients and existed for 
hospital volume but not for surgeon volume 
after AVR [25]. There have been various factors 
that can explain the progressive decline in mor-
tality rates after aortic valve surgery. These 
would include earlier diagnosis and access to 
surgery, improvements in risk stratification and 
prosthesis-patient matching, advancements in 
surgical techniques, increase in high volume 
surgical centers, and meticulous perioperative 
care with early mobilization. Improvement in 
surgical technic such as minimal invasive ap- 
proach is promising with some data suggest- 
ing improvement in outcome [26]. Despite im- 
provement in surgical techniques, women have 
higher mortality during any cardiac surgery due 
to age and having more comorbidities [27].
Conclusion
Age adjusted mortality from aortic valve sur-
gery has been gradually decreasing in the last 
decade suggesting improvement in surgical te- 
chnics and post-surgical care.
Limitations
This study was based on ICD 9 coding with 
inherent limitation of ICD-9 coding. Our study 
evaluated in-hospital mortality and not long-
term mortality. We did not evaluate the effect 
of different techniques on outcome such as on 
or off pump surgical approach. 
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